Monsenso AS (MONSO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Monsenso AS (MONSO) has a cash flow conversion efficiency ratio of -0.251x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-1.68 Million ≈ $-263.16K USD) by net assets (Dkr6.71 Million ≈ $1.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Monsenso AS for the company's overall valuation and market capitalisation.
Monsenso AS - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Monsenso AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Monsenso AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Monsenso AS ranked by their cash flow conversion efficiency. Explore Monsenso AS cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
YouGov plc
LSE:YOU
|
0.045x |
|
Raja Ferry Port Public Company Limited
BK:RP
|
0.059x |
|
Vnsteel Vicasa JSC
VN:VCA
|
N/A |
|
Elanor Investors Group
AU:ENN
|
-0.139x |
|
Minco Capital Corp
V:MMM
|
0.009x |
|
TomaGold Corporation
F:OTM
|
-0.346x |
|
Tesoro Minerals Corp.
V:TES
|
-0.178x |
|
BIOVAXYS TECHNOLOGY CORP.
F:5LB
|
N/A |
Annual Cash Flow Conversion Efficiency for Monsenso AS (2016–2025)
The table below shows the annual cash flow conversion efficiency of Monsenso AS from 2016 to 2025. View MONSO share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Dkr6.98 Million ≈ $1.09 Million |
Dkr-1.49 Million ≈ $-233.12K |
-0.214x | +56.98% |
| 2024-12-31 | Dkr14.16 Million ≈ $2.22 Million |
Dkr-7.03 Million ≈ $-1.10 Million |
-0.497x | -311.56% |
| 2023-12-31 | Dkr10.87 Million ≈ $1.70 Million |
Dkr2.55 Million ≈ $399.28K |
0.235x | +202.16% |
| 2022-12-31 | Dkr14.76 Million ≈ $2.31 Million |
Dkr-3.39 Million ≈ $-530.39K |
-0.230x | -12.40% |
| 2021-12-31 | Dkr21.44 Million ≈ $3.35 Million |
Dkr-4.38 Million ≈ $-685.75K |
-0.204x | -231.21% |
| 2020-12-31 | Dkr18.65 Million ≈ $2.92 Million |
Dkr2.91 Million ≈ $454.66K |
0.156x | +386.64% |
| 2019-12-31 | Dkr3.86 Million ≈ $604.55K |
Dkr-210.00K ≈ $-32.86K |
-0.054x | +91.70% |
| 2018-12-31 | Dkr3.82 Million ≈ $597.20K |
Dkr-2.50 Million ≈ $-390.99K |
-0.655x | -28.52% |
| 2017-12-31 | Dkr4.91 Million ≈ $767.42K |
Dkr-2.50 Million ≈ $-390.94K |
-0.509x | -32.62% |
| 2016-12-31 | Dkr6.51 Million ≈ $1.02 Million |
Dkr-2.50 Million ≈ $-390.94K |
-0.384x | -- |
About Monsenso AS
Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution,… Read more